Avoiding contrast dyes for imaging tests not necessary if concerned about iodine allergy, peer-reviewed study concludes #MRI
News | Contrast Media Injectors
New Research Shatters Age-old Iodine Allergy Myth

September 16, 2021 — FDB (First Databank), a leading provider of drug and medical device knowledge that helps healthcare ...

Time September 16, 2021
Home
Strategies to help guide nuclear radiology teams at various healthcare systems in 2021 and beyond
Feature | Nuclear Imaging | By Staff of the American Society of Nuclear Cardiology (ASNC)
5 Strategies for Improving Your Nuclear Radiology Lab

A year after COVID-19 turned the world upside down, the American Society of Nuclear Cardiology (ASNC) asked members how ...

Time September 16, 2021
Home
This is an example of 3-D ultrasound imaging on a breast, designed to help increase efficiency and diagnostic accuracy in any practice. Image courtesy of Hologic.
Feature | Breast Imaging | By Jennifer Meade
Trends in Breast Ultrasound

The breast ultrasound market is seeing growth, driven largely by the proliferation of recent legislation aimed at ...

Time September 15, 2021
Home
While the Mammography Quality Standards Act (MQSA) and the introduction of EQUIP (Enhancing Quality Using the Inspection Program) have been successful in standardizing and enhancing mammographic imaging quality, inadequate breast positioning can dramatically impact the ability of radiologists and technicians to quickly and accurately detect breast cancer and potentially malignant lesions in their patients
Feature | Mammography | By Christopher Austin, M.D. and Randy D. Hicks, M.D., MBA
The Essential Role of Breast Positioning

During mammography, proper breast positioning is critical to the radiologist’s ability to identify potential lesions ...

Time September 15, 2021
Home
Revised guidelines for lung cancer screening eligibility are perpetuating disparities for racial/ethnic minorities, according to a new study in Radiology.
News | Lung Imaging
Racial/Ethnic Disparities Persist in Lung Cancer Screening Eligibility

September 15, 2021 — Revised guidelines for lung cancer screening eligibility are perpetuating disparities for racial ...

Time September 15, 2021
Home
To get more flexibility and cost savings from storage, healthcare organizations are increasing their investments in the cloud
Feature | Information Technology | By Kumar Goswami
Big Medical Image Files with Nowhere to Go

Healthcare organizations today are storing petabytes of medical imaging data — lab slides, X-rays, magnetic resonance ...

Time September 15, 2021
Home
Revenues for teleradiology reading service providers are forecast to follow a similar profile over this period.
Feature | Teleradiology | By Arun Gill
6 Key Drivers to Restoring Teleradiology

The closely tied relationship between teleradiology reading services and diagnostic imaging procedures resulted in an ...

Time September 15, 2021
Home
Siemens Healthineers announced the Food and Drug Administration (FDA) clearance of the SOMATOM X.ceed, a premium single-source computed tomography (CT) scanner that combines high-speed scanning capabilities and a level of resolution previously unseen in other single-source CT systems with a new hardware/software combination to simplify CT-guided interventions.
News | Computed Tomography (CT)
Siemens Healthineers SOMATOM X.ceed Premium Single-source CT Scanner Cleared by FDA

September 15, 2021 — Siemens Healthineers announced the Food and Drug Administration (FDA) clearance of the SOMATOM X ...

Time September 15, 2021
Home
Changing business models require the adoption of new technologies to remain efficient and effective
Feature | Information Technology | By Chris Patrick
Streamlining Productivity with Radiology Informatics

Does it take a global pandemic to change the way providers deliver care? COVID-19 brought an impact to many healthcare ...

Time September 15, 2021
Home
Cloud services have been utilized within healthcare organizations for more than a decade. Now with the growth of artificial intelligence (AI) it is very common to see organizations adopting cloud services.
Feature | Information Technology | By Jef Williams
Adopting Cloud — A Path Forward

Cloud solutions have been discussed and promoted within healthcare for more than 10 years. I recall the early 2010s ...

Time September 14, 2021
Home
Figure 1: MWT Schematic of a typical setup for detecting malignant tissues/tumors.
Feature | Radiology Imaging | By Brendon McHugh
How SDR is Enabling the Emerging Field of Microwave Tomography

While microwave tomography (MWT) imaging has been around for a few decades, advances in computing power, artificial ...

Time September 14, 2021
Home
As with all imaging technologies, COVID-19 is expected to continue to negatively impact the market.
Feature | Magnetic Resonance Imaging (MRI) | By Melinda Taschetta-Millane
Incorporating Artificial Intelligence Into MRI

According to a new report produced by Grand View Research, the global magnetic resonance imaging (MRI) market size was ...

Time September 14, 2021
Home
Evaluation of therapeutic efficacy of drug candidates in preclinical oncology with positron emission tomography (PET)
Feature | PET Imaging | By Todd Sasser, Ph.D.
The Role of PET Imaging in Preclinical Oncology

The use of positron emission tomography (PET) imaging in preclinical oncology investigations has shown the ability to ...

Time September 14, 2021
Home
Comparison Charts
Radiation Therapy Quality Assurance Platforms
Time
Home
Us2.ai, a Singapore-based medtech firm backed by Sequoia India and EDBI, has received U.S. Food and Drug Administration (FDA) clearance for Us2.v1, a completely automated AI decision support tool for cardiac ultrasound.
News | Cardiovascular Ultrasound
FDA Clears Fully Automated Cardiac Ultrasound Solution to Measure 2D and Doppler

September 14, 2021 – Us2.ai, a Singapore-based medtech firm backed by Sequoia India and EDBI, has received U.S. Food and ...

Time September 14, 2021
Home
Lantheus Holdings, Inc. and RefleXion Medical, Inc., today announced a development and commercialization collaboration to evaluate the use of piflufolastat F 18, Lantheus’ prostate-specific membrane antigen (PSMA)-targeted positron emission tomography (PET) imaging agent, to enable real-time therapeutic guidance of biology-guided radiotherapy (BgRT) in prostate cancer using the RefleXion X1 platform. 
News | PET Imaging
Lantheus and RefleXion Announce Collaboration with Potential to Improve Future Prostate Cancer Treatment

September 13, 2021 — Lantheus Holdings, Inc. and RefleXion Medical, Inc., today announced a development and ...

Time September 13, 2021
Home
With a wealth of landmark studies in Breast, Cervical, Melanoma, Prostate, Colorectal, Oesophagus, Endocrine and Lung cancer, the ESMO Congress 2021 is a clear demonstration that oncology research has once again gathered momentum after being temporarily stopped in its tracks by the outbreak of the virus
News | Radiation Oncology
Oncology Research Rebounds from Pandemic Low, But Shows Cancer Patients Need Attention After COVID-19 Recovery

September 13, 2021 — At the opening press conference of the ESMO Congress 2021, President Solange Peters announced that ...

Time September 13, 2021
Home
Plan to attend RSNA21 at McCormick Place Chicago, Nov. 28 – Dec. 2, 2021
News | RSNA
RSNA 2021 Showcases Latest Imaging Technologies, Solutions

September 13, 2021 — The Radiological Society of North America (RSNA) today announced highlights of the Technical ...

Time September 13, 2021
Home
Ikonopedia announced that it has added Banner Health, one of the largest non-profit health care systems in the country, as a customer and will implement its entire suite of structured breast imaging reporting and MQSA management tools. The installation is designed to help streamline processes, improve reporting efficiency and optimize facility operations across the Banner Health network.
News | Breast Imaging
Ikonopedia to Implement Comprehensive Suite of Breast Imaging Report Generation and MQSA Management Capabilities at Banner Health

September 10, 2021 — Ikonopedia announced that it has added Banner Health, one of the largest non-profit health care ...

Time September 10, 2021
Home
NorthStar Medical Radioisotopes, LLC, a global innovator in the development, production and commercialization of radiopharmaceuticals used for therapeutic applications and medical imaging, and POINT Biopharma Global Inc. (NASDAQ: PNT), a company accelerating the discovery, development, and global access to life changing radiopharmaceuticals, today announced the signing of a supply agreement for the therapeutic medical radioisotope actinium-225 (Ac-225).
News | Radiopharmaceuticals and Tracers
NorthStar Medical Radioisotopes and POINT Biopharma Announce Supply Agreement for Therapeutic Medical Radioisotope Actinium-225

September 10, 2021 — NorthStar Medical Radioisotopes, LLC, a global innovator in the development, production and ...

Time September 10, 2021
Home
© Copyright Wainscot Media. All Rights Reserved.
Subscribe Now